Total Funding
61
56
Total FundingDebt Financing raised
Growth Score
-2 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
115304
SUN bioscience creates advanced cell culture platforms.
- Sylke Hoehnel: CEO & Co-Founder
- Nathalie Brandenberg: COO & Co-Founder
About the Company
SUN bioscience is enabling personalized medicine through patient-specific organoids cultured on SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and
toxicity early on in drug development.
The SUN technology is solving the problems that organoid culture today cannot be scaled and automated. This will introduce a new area of drug discovery where we can understand drug performance outside of an animal or a human being.
